MLTX 241220 70.00P (MLTX241220P70000) Stock Options, News & Quotes

US OptionsDetailed Quotes

MLTX241220P70000

Watchlist

0.00
0.000.00%

15min DelayClose Nov 22 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

MoonLake Immunotherapeutics' Promising SLK Therapy Forecasts Strong Market Performance and Stock Potential
TipRanksNov 21 06:06 ET
UCB Gets FDA Approval for Bimzelx for Hidradenitis Suppurativa
Seeking AlphaNov 20 10:34 ET
MoonLake Immunotherapeutics Management to Meet With Oppenheimer
TipRanksNov 18 10:30 ET
Wedbush Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Maintains Target Price $73
Moomoo NewsNov 14 10:31 ET · Ratings
MoonLake Immunotherapeutics' Promising Phase 3 Trials for PsA Treatment Drives Buy Rating
TipRanksNov 14 09:55 ET · Ratings
Oppenheimer Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Maintains Target Price $104
Moomoo NewsNov 14 08:35 ET · Ratings

Comments

Bigmoney Dreamer

Mar 21 17:20

$MoonLake Immunotherapeutics (MLTX.US)$ 🐂 trend indicator crossover may run big

Meltyy

Jan 24 03:25

Ph2 readouts in Q1 2024...

$Pfizer (PFE.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$Vera Therapeutics (VERA.US)$ Phase 2b
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$Akero Therapeutics (AKRO.US)$ Phase 2b
$Spruce Biosciences (SPRB.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$Annexon (ANNX.US)$ Phase 2a
$Roivant Sciences (ROIV.US)$...

Meltyy

Jan 3 06:11

Upcoming Ph 2 readouts in Q1 2024…

$Cellectar BioSciences (CLRB.US)$ Phase 2
$Regenxbio (RGNX.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals (EYPT.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 2
$Disc Medicine (IRON.US)$ Phase 2
$Atea Pharmaceuticals (AVIR.US)$ Phase 2
$Allakos (ALLK.US)$ Phase 2...

Moomoo AI

Oct 16, 2023 06:34

MoonLake's CEO expresses confidence in 120mg being the optimal dose and highlights the drug's improved durability of response compared to Humira in other studies.

MoonLake Stock Rises After Skin Disorder Drug Shows Promise in Phase 2 Trial

Weight-loss drugmakers report strong earnings: Boon or bane?

Rivera

Aug 16, 2023 07:21

Caming up

$MoonLake Immunotherapeutics (MLTX.US)$